Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Cessation of alcohol and smoking to prevent acute pancreatitis recurrence

Official title: Recurrent Acute Pancreatitis Prevention by the Elimination of Alcohol and Cigarette Smoking (REAPPEAR): Protocol of a Randomized Controlled Trial and a Cohort Study

Run by University of Pecs · NCT04647097 · Data updated 2026-11-12

This study is testing whether quitting alcohol and smoking can help people who have had acute pancreatitis avoid getting it again.

More Acute Pancreatitis trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment364 (estimated)
SponsorUniversity of Pecs
Academic / other
Locations1 site (Pécs)
StatusRecruiting
StartedMarch 1, 2022
Main results expectedDecember 31, 2027
Study endsJune 30, 2028
Registry record updatedApril 26, 2023
Trial IDNCT04647097 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are daily smokers aged 18-80 who have been hospitalized for alcohol-induced acute pancreatitis.

Probably not a fit

Patients with acute pancreatitis caused by factors other than alcohol or those with severe psychiatric illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a lifestyle intervention aimed at preventing the recurrence of acute pancreatitis by promoting the cessation of alcohol consumption and smoking. It includes a randomized controlled trial and a cohort analysis to assess the impact of these lifestyle changes on patients hospitalized with alcohol-induced pancreatitis. Participants will receive standard cessation interventions and will be monitored for changes in motivation, addiction, quality of life, and socioeconomic status over time. Laboratory tests and biomarker measurements will also be conducted to evaluate the intervention's efficacy.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the recurrence of acute pancreatitis in patients who consume alcohol and smoke.

How similar studies have gone: While there is clinical equipoise regarding the impact of alcohol and smoking cessation, this study aims to fill a gap in the literature, as well-designed clinical trials on this topic are lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Patient hospitalized with alcohol-induced AP (defined by the revised Atlanta criteria 38)
* Every day smoker (defined as an adult patient who smoked at least 100 cigarettes in his or her lifetime, and now smokes on a daily basis; as per the CDC definition), with at least 1-year history of smoking
* Aged 18-80 years
* Provided written informed consent
* Willing to participate in the intervention in every three months

Exclusion criteria:

* Possible etiologies for AP other than alcohol (eg. gallstone-related, hypertriglyceridemia above 11.5 mM 40-42, hypercalcemia, viral infection) if the etiological cannot be terminated during the index admission (lack of same admission cholecystectomy, familiar hypertrygliceridemia) and cases with combined etiological factors will be excluded
* Untreated, decompensated or severe mMajor psychiatric illnesses (e.g. schizophrenia, bipolar disorder, dementia)
* Currently taking part in a smoking cessation program
* Undergoing active or palliative treatment for malignancy
* Pregnancy, breastfeeding
* Life expectancy is less than two years
* Didn't agreed to participate
* Other

Where it's running

  • Institute for Translational Medicine, University of Pécs
    Pécs, Hungary
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.